Document 0583 DOCN M9460583 TI Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. DT 9404 AU Howell AL; Guyre PM; You K; Fanger MW; Department of Medicine, Dartmouth Medical School, Lebanon, NH; 03755-3842. SO J Leukoc Biol. 1994 Mar;55(3):385-91. Unique Identifier : AIDSLINE MED/94165577 AB In addition to CD4, the primary receptor to which the human immunodeficiency virus type 1 (HIV-1) binds, mononuclear phagocytes (monocytes) express three classes of Fc receptors for immunoglobulin G (Fc gamma R). We have previously shown that infection of monocytes by HIV-1 is inhibited when bispecific antibodies (BsAbs) are used to target the virus to either the type I, type II, or type III Fc gamma R on these cells. Infection of monocytes was not inhibited when HIV-1 was targeted to either human leukocyte antigen class I or CD33. We have extended these studies to examine the ability of BsAbs plus polymorphonuclear leukocytes (neutrophils, PMNs) and monocytes to reduce infectivity of HIV-1 to cells from the human T cell lymphoma line, H9. The production of HIV-1 following interaction of virus with BsAb and phagocytes was determined in an indicator cell assay by mixing BsAb, HIV-1, and phagocytes with uninfected H9 cells. Productive infection of H9 cells was quantitated on subsequent days by measuring p24 gag antigen levels in supernatants by enzyme-linked immunosorbent assay. Our findings show that the addition of interferon-gamma-activated PMNs or monocytes to cultures of HIV-1 plus H9 cells in the absence of BsAb results in a marked reduction in p24 levels equivalent to 85 to 90% of control levels. With the combination of BsAb (anti-Fc gamma RI x anti-gp120) plus IFN-gamma-activated phagocytes, levels of p24 in H9 cultures were below those at culture initiation. These findings demonstrate that IFN-gamma-activated phagocytes can affect the natural course of HIV-1 infection of T cells, a finding of potential clinical importance. DE Acquired Immunodeficiency Syndrome/IMMUNOLOGY *Antibody Specificity Cells, Cultured Enzyme-Linked Immunosorbent Assay Fluorescent Antibody Technique Human HIV Antibodies/*IMMUNOLOGY/PHARMACOLOGY HIV Core Protein p24/ANALYSIS/METABOLISM HIV-1/ISOLATION & PURIF/*METABOLISM/*PHYSIOLOGY IgG/METABOLISM/PHARMACOLOGY Immunity, Natural Interferon Type II/PHARMACOLOGY Monocytes/CHEMISTRY/CYTOLOGY/ULTRASTRUCTURE Neutrophils/CHEMISTRY/CYTOLOGY/ULTRASTRUCTURE Phagocytes/*CHEMISTRY/*CYTOLOGY/ULTRASTRUCTURE Receptors, IgG/*ANALYSIS/METABOLISM Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. Support, U.S. Gov't, P.H.S. T-Lymphocytes/*CYTOLOGY/*MICROBIOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).